EUVIMEDEUVIMED entdecken
Crossref

ALKBH5-Mediated Destabilization of ARAP2 mRNA Promotes Cisplatin Resistance in HPV+ Oropharyngeal Cancer

Yurong He, Siyu Zhu, Boxuan Han, Yanming Zhao, Haiyang Li, Yueyue Shi, Xinyu Li, Ru Wang, Qian Shi, Yang Zhang, Qi Zhong, Jugao Fang und 1 weitere

The American Journal of Pathology · 2026-11

DOI: 10.1016/j.ajpath.2026.11.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Pathology, 2026-11. Verfasst von Yurong He und 12 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

He, Y., Zhu, S., Han, B., Zhao, Y., Li, H., Shi, Y., Li, X., Wang, R., Shi, Q., Zhang, Y., Zhong, Q., Fang, J., & He, S. (2026). ALKBH5-Mediated Destabilization of ARAP2 mRNA Promotes Cisplatin Resistance in HPV+ Oropharyngeal Cancer. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2026.11.001

Vancouver

He Y, Zhu S, Han B, Zhao Y, Li H, Shi Y, et al. ALKBH5-Mediated Destabilization of ARAP2 mRNA Promotes Cisplatin Resistance in HPV+ Oropharyngeal Cancer. The American Journal of Pathology. 2026. doi:10.1016/j.ajpath.2026.11.001

BibTeX
@article{He2026,
  author = {He, Yurong and Zhu, Siyu and Han, Boxuan and Zhao, Yanming and Li, Haiyang and Shi, Yueyue and Li, Xinyu and Wang, Ru and Shi, Qian and Zhang, Yang and Zhong, Qi and Fang, Jugao and He, Shizhi},
  title = {ALKBH5-Mediated Destabilization of ARAP2 mRNA Promotes Cisplatin Resistance in HPV+ Oropharyngeal Cancer},
  journal = {The American Journal of Pathology},
  year = {2026},
  doi = {10.1016/j.ajpath.2026.11.001}
}
Kostenlos starten →